IP Library › Granted Patent US 7,223,888
Granted Patent B2
US 7,223,888 · App. 10/683,756 · Granted May 29, 2007

Mu opioid receptor ligands: methods of use and synthesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,888
App. No.
10/683,756
Granted
May 29, 2007
Kind
B2
Abstract

Novel compounds and compositions including those compounds, as well as methods of using and making the compounds are herein described. The compounds are useful in therapeutic applications, including modulation of disease or disease symptoms in a subject (e.g., mammal, human, dog, cat, horse). The compounds are useful as modulators of the mu opioid receptor (MOR) through their binding affinity with that receptor.

Claims (289)

1. A compound of the formula (I):

wherein,

each R 1 , R 2 , and R 3 are independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

X is N;

R 4 is H, CON(R 7 ) 2 , CONHR 7 , CH 2 OH, CH(OH)CH═CH 2 , or C(O)NHCHR 10 CO 2 H;

each R 5 is independently H, alkyl, alkenyl, aryl, heteroaryl, acyl, P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 2 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 10 is independently an amino acid side chain;

each P 1 and P 2 is independently a nitrogen protecting group; and

each P 3 is independently an oxygen protecting group;

or pharmaceutically acceptable salts thereof.

2. The compound of claim 1 , wherein:

X is N;

R 1 is alkyl substituted with aryl, which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

R 4 is H, CON(R 7 ) 2 , C(O)NHCHR 10 CO 2 H, or CH 2 OH;

each R 5 is independently H, alkyl, acyl, P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 2 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 10 is independently an amino acid side chain;

each P 1 and P 2 is independently a nitrogen protecting group; and

each P 3 is independently an oxygen protecting group.

3. The compound of claim 1 , wherein:

X is N;

R 1 is alkyl substituted with aryl, which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , halo, or C 1-6 alkyl;

R 4 is H, CONHR 7 , or CH 2 OH;

each R 5 is independently H or alkyl;

each R 6 is independently H or alkyl;

R 7 is H, alkyl, or P 2 ; and

P 2 is a nitrogen protecting group.

4. The compound of claim 1 , wherein:

X is N;

R 1 is alkyl substituted with aryl, which is optionally substituted with 1–5 substituents selected from OH or C 1-6 alkyl; and

R 4 is H, CONH 2 , or CH 2 OH.

5. The compound of claim 1 , wherein:

X is N;

R 1 is C 1 alkyl substituted with phenyl, which is substituted at the 2- and 6-positions with Me and is substituted at the 4-position with OH; and

R 4 is H, CONH 2 , or CH 2 OH.

6. The compound of claim 1 having the formula (II):

wherein,

X is N;

R 4 is H, CON(R 7 ) 2 , CONHR 7 , CH 2 OH, or C(O)NHCHR 10 CO 2 H;

each R 5 is independently H, alkyl, acyl, P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 2 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 9 is independently OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

each R 10 is independently an amino acid side chain;

each n is independently 0, 1, 2, 3, 4, or 5;

each P 1 and P 2 is independently a nitrogen protecting group; and

each P 3 is independently an oxygen protecting group.

7. The compound of claim 6 , wherein:

R 4 is H, CON(R 7 ) 2 , CONHR 7 , or CH 2 OH;

each R 5 is independently H, alkyl, or acyl;

each R 6 is independently H or alkyl;

each R 7 is independently H or alkyl;

each R 9 is independently OR 6 , CN, NO 2 , halo, or C 1-6 alkyl; and

each n is independently 0 1, 2, or 3.

8. The compound of claim 6 , wherein:

P 1 is a BOC or Fmoc;

P 2 is a solid support; and

P 3 is t-Bu, Bn, Me, or Ac.

9. The compound of claim 6 , wherein:

R 4 is H, CON(R 7 ) 2 , CONHR 7 , or CH 2 OH;

each R 5 is independently H, alkyl, acyl, or P 1 ;

each R 6 is independently H or P 3 ;

each R 7 is independently H or P 2 ;

each R 9 is independently OR 6 or C 1-6 alkyl;

each n is independently 0, 1, or 2;

P 1 is a BOC;

P 2 is a solid support; and

P 3 is t-Bu.

10. The compound of claim 6 , wherein:

R 4 is H, CONH 2 , or CH 2 OH;

each R 5 is independently H, P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is H or alkyl

each R 9 is C 1-6 alkyl or OR 6 ;

each R 10 is independently an amino acid side chain;

each n is independently 1, 2, or 3; and

P 1 is a nitrogen protecting group.

11. The compound of claim 1 that is formula (III):

wherein,

X is N;

R 9 is C 1-6 alkyl; and

n is 2.

12. The compound of claim 1 that is formula (IV):

wherein X is N.

13. The compound of claim 1 having the formula (V):

wherein

X is N; and

R 4 is CONH 2 , H, or CH 2 OH.

14. The compound of claim 1 having the formula (VI):

wherein,

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

R 4 is H, CON(R 7 ) 2 , CONHR 7 , CH 2 OH, or CH(OH)CH═CH 2 , or C(O)NHCHR 10 CO 2 H;

each R 5 is independently H, alkyl, alkene, aryl, heteroaryl, acyl, or P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl acyl, or P 2 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 10 is independently an amino acid side chain;

each P 1 and P 2 is independently a nitrogen protecting group; and

each P 3 is independently an oxygen protecting group.

15. The compound of claim 14 , wherein:

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , halo, or C 1-6 alkyl;

R 4 is H, CON(R 7 ) 2 , or CONHR 7 , or C(O)NHCHR 10 CO 2 H;

each R 5 is independently H, alkyl, acyl, P 1 , or C(O)CHR 10 NH 2 ; and

each R 10 is independently an amino acid side chain.

16. A method of making a compound of the formula (VIII):

comprising coupling compounds of the formulas (XI) and (XII)

using a ruthenium catalyst, to give a compound of formula (IX); and

reacting the compound of formula (IX) with a deprotecting agent to give a compound of the formula (VIII);

wherein,

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N( 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 4 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 11 , R 12 , and R 13 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 16 , CN, NO 2 , NHR 17 , N(R 17 ) 2 , halo, CONHR 17 , CON(R 17 ) 2 , CO 2 R 18 , or C 1-6 alkyl;

each R 16 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 4 ;

each R 18 is independently H, alkyl, aralkyl, or heteroaralkyl;

each P 1 , P 2 , and P 4 is independently a nitrogen protecting group; and

each P 3 is independently an oxygen protecting group.

17. A method of making a compound of the formula (XVI):

comprising coupling compounds of the formulas (XI) and (XIII)

by first reacting the free alcohols with a silicon protecting group, and then treating the resulting compound with a ruthenium catalyst, giving a compound of the formula (VII);

reacting the compound of formula (VII) under pH conditions sufficient to remove acid labile protecting groups, if any;

treating the resulting product with peroxide and base under conditions sufficient to hydrolyze the thioester; and

coupling the resulting product with a solid phase peptide, giving a compound of the formula (XVI);

wherein,

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 4 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 11 and R 12 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 16 , CN, NO 2 , NHR 17 , N(R 17 ) 2 , halo, CONHR 17 , CON(R 17 ) 2 CO 2 R 18 , or C 1-6 alkyl;

each R 16 is independently H, alkyl, or P 3 ;

each R 17 is independently H, alkyl, acyl, or P 4 ;

each R 18 is independently H, alkyl, aralkyl, or heteroaralkyl;

each P 1 and P 4 is independently a nitrogen protecting group; and

each P 3 is independently an oxygen protecting group; and

P 5 is a sulfur protecting group.

18. A method of making a compound of the formula (XIV):

comprising coupling compounds of formulas (XI) and (XIII),

with a ruthenium catalyst;

treating the resulting compound with peroxide and base under conditions sufficient to hydrolyze the thioester;

amidation or esterification of the resulting acid; and

treatment of the resulting compound with a deprotecting agent sufficient to remove protecting groups, giving a compound of the formula (XIV);

wherein,

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

X is N;

R 4 is H, CON(R 7 ) 2 , CONHR 7 , CH 2 OH, or CH(OH)CH═CH 2 ;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 4 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 11 and R 12 are independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 16 , CN, NO 2 , NHR 17 , N(R 17 ) 2 , halo, CONHR 17 , CON(R 17 ) 2 , CO 2 R 18 , or C 1-6 alkyl;

each R 16 is independently H, alkyl, or P 3 ;

each R 17 is independently H, alkyl, acyl, or P 4 ;

each R 18 is independently H, alkyl, aralkyl, or heteroaralkyl;

each P 1 and P 4 is independently a nitrogen protecting group;

each P 3 is independently an oxygen protecting group; and

P 5 is a sulfur protecting group.

19. A method of making a compound of formula (XVII):

comprising coupling compounds of formulas (XI) and (XIII)

with a ruthenium catalyst;

treating the resulting compound with peroxide and base under conditions sufficient to hydrolyze the thioester; and

reacting the free hydroxyls with an oxygen protecting group to give a compound of formula (XVIII)

coupling the compound of formula (XVIII) with an alcohol of formula R 13 (CHOH)CHOR 16 ; and

treating the resulting compound with a deprotecting agent sufficient to remove protecting groups to give a compound of formula (XVII);

wherein,

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 4 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 11 , R 12 , and R 13 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 16 , CN, NO 2 , NHR 17 , N(R 17 ) 2 , halo, CONHR 17 , CON(R 17 ) 2 CO 2 R 18 , or C 1-6 alkyl;

each R 16 is independently H, alkyl, or P 3 ;

each R 17 is independently H, alkyl, acyl, or P 4 ;

each R 18 is independently H, alkyl, aralkyl, or heteroaralkyl;

each P 1 and P 4 is independently a nitrogen protecting group;

each P 3 is independently an oxygen protecting group; and

P 5 is a sulfur protecting group.

20. A composition comprising a compound of formula (I) in claim 1 and a pharmaceutically acceptable carrier.

21. A compound of formula (XIX):

wherein,

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

X is N;

R 4 is H, CON(R 7 ) 2 , CONHR 7 , CH 2 OH, CH(OH)CH═CH 2 , or C(O)NHCHR 10 CO 2 H;

each R 5 is independently H, alkyl, alkenyl, aryl, heteroaryl, acyl, P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 2 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 10 is independently an amino acid side chain;

each P 1 and P 2 is independently a nitrogen protecting group;

each P 3 is independently an oxygen protecting group; and

or pharmaceutically acceptable salts thereof.

22. The compound of claim 21 wherein:

X is N;

R 1 is alkyl substituted with aryl, which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

R 4 is H, CON(R 7 ) 2 , C(O)NHCHR 10 CO 2 H, or CH 2 OH; and

each R 5 is independently H, alkyl, acyl, P 1 , or C(O)CHR 10 NH 2 ;

each R 10 is independently an amino acid side chain.

23. The compound of claim 21 , wherein:

X is N;

R 1 is alkyl substituted with aryl, which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , halo, or C 1-6 alkyl;

R 4 is H, CONHR 7 , or CH 2 OH;

each R 5 is independently H or alkyl;

each R 6 is independently H or alkyl; and

R 7 is H, alkyl, or P 2 .

24. The compound of claim 21 , wherein:

X is N;

R 1 is alkyl substituted with aryl, which is optionally substituted with 1–5 substituents selected from OH or C 1-6 alkyl; and

R 4 is H, CONH 2 , or CH 2 OH.

25. The compound of claim 21 , wherein:

X is N;

R 1 is C 1 alkyl substituted with phenyl, which is substituted at the 2- and 6-positions with Me and is substituted at the 4-position with OH; and

R 4 is H, CONH 2 , or CH 2 OH.

26. The compound of claim 21 , wherein

X is N;

R 1 is methyl substituted with phenyl, which is substituted at the 4-position with OH; and

R 4 is CONH 2 .

27. The compound of claim 21 having the formula (XX):

wherein,

X is N;

R 4 is H, CON(R 7 ) 2 , CONHR 7 , CH 2 OH, or C(O)NHCHR 10 CO 2 H;

each R 5 is independently H, alkyl, acyl, P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl; or P 2 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 9 is independently OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 8 , or C 1-6 alkyl;

each R 10 is independently an amino acid side chain;

each n is independently 0, 1, 2, 3, 4, or 5;

each P 1 and P 2 is independently a nitrogen protecting group; and

each P 3 is independently an oxygen protecting group.

28. The compound of claim 27 , wherein:

R 4 is H, CON(R 7 ) 2 , CONHR 7 , or CH 2 OH;

each R 5 is independently H, alkyl, or acyl;

each R 6 is independently H or alkyl;

each R 7 is independently H or alkyl;

each R 9 is independently OR 6 , CN, NO 2 , halo, or C 1-6 alkyl; and

each n is independently 0 1, 2, or 3.

29. The compound of claim 27 , wherein:

R 4 is H, CON(R 7 ) 2 , CONHR 7 , or CH 2 OH;

each R 5 is independently H, alkyl, acyl, or P 1 ;

each R 7 is independently H or P 2 ;

each R 9 is independently OR 6 or C 1-6 alkyl;

each n is independently 0 or 1;

P 1 is a BOC;

P 2 is a solid support; and

P 3 is t-Bu.

30. The compound of claim 27 , wherein:

R 4 is H, CONH 2 , or CH 2 OH;

each R 5 is independently H, P 1 , or C(O)CHR 10 NH 2 ;

each R 6 is H or alkyl

each R 9 is C 1-6 alkyl or OR 6 ;

each R 10 is independently an amino acid side chain;

each n is independently 1, 2, or 3; and

P 1 is a nitrogen protecting group.

31. The compound of claim 21 having the formula (XXI):

wherein,

X is N;

R 4 is H, CONH 2 , or CH 2 OH;

R 9 is C 1-6 alkyl; and

n is 2.

32. The compound of claim 21 having the formula (XXII):

wherein

R 2 is C 1-6 alkyl; and

n is 0, 1, or 2.

33. A method of making a compound of formula (XXIII):

comprising coupling compounds of formulas (XXV) and (XIII)

using a ruthenium catalyst, giving a compound of the formula (XXIV);

treating the resulting product with peroxide and base under conditions sufficient to hydrolyze the thioester;

coupling the resulting product with a solid phase peptide; and

treating the resulting compound with a deprotecting agent, giving a compound of the formula (XXIII);

wherein,

each R 1 , R 2 , and R 3 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 6 , CN, NO 2 , NHR 7 , N(R 7 ) 2 , halo, CONHR 7 , CON(R 7 ) 2 , CO 2 R 1 , or C 1-6 alkyl;

each R 6 is independently H, alkyl, or P 3 ;

each R 7 is independently H, alkyl, acyl, or P 4 ;

each R 8 is independently H, alkyl, aralkyl, or heteroaralkyl;

each R 11 and R 12 is independently alkyl substituted with aryl or heteroaryl, each of which is optionally substituted with 1–5 substituents selected from OR 16 , CN, NO 2 , NHR 17 , N(R 17 ) 2 , halo, CONHR 17 , CON(R 17 ) 2 , CO 2 R 18 , or C 16 alkyl;

each R 16 is independently H, alkyl, or P 3 ;

each R 17 is independently H, alkyl, acyl, or P 4 ;

each R 18 is independently H, alkyl, aralkyl, or heteroaralkyl;

each P 1 and P 4 is independently a nitrogen protecting group;

each P 3 is independently an oxygen protecting group; and

P 5 is a sulfur protecting group.

34. A composition comprising a compound of formula (XIX) in claim 21 or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier.

35. A method of treating a mu opioid receptor (MOR) mediated disorder that is pain in a subject comprising administering a compound of formula (I) in claim 1 or a compound of formula (XIX) in claim 21 or pharmaceutically acceptable salts thereof.

36. A method of treating a mu opioid receptor (MOR) mediated disorder that is pain in a subject comprising administering a composition comprising a compound of formula (I) in claim 1 or a compound of formula (XIX) in claim 21 or pharmaceutically acceptable salts thereof.

37. A method of treating pain in a subject, comprising administering to the subject a compound of formula (I) in claim 1 or of formula (XIX) in claim 21 or pharmaceutically acceptable salts thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2004
From: HARRISON, BRYCE A.; GIERASCH, TIFFANY M.; VERDINE, GREGORY L.; SHI, ZHANGIE
To: HARVARD COLLEGE, PRESIDENT AND FELLOWS OF
Reel/Frame 015057/0493 →